Dr Lal Pathlabs Ltd.

BSE: 532540 NSE: Dr Lal Pathlabs ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Dr Lal Pathlabs Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS
About

Dr Lal Pathlabs

Its the Indian No-1 multinational information service and consulting Provider company. Dr Lal Pathlabs is the Subsidiary Company of TATA Group and it’s founded in 1968.

Dr Lal Pathlabs Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Dr Lal Pathlabs is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020

Dr Lal Pathlabs Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 10 Years (CG)Next 20 Years (CG)

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Years (CG+5%)Next 10 Years (CG+5%)Next 20 Years (CG+5%)

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 5 Years (CG-5%)Next 20 Years (CG-5%)Next 10 Years (CG-5%)

Dr Lal Pathlabs Quarterly Result, Date & Street Estimate:

Share NameQuarter ResultsYearStreet EstimatesProfitsGrowth

Fundamental Analysis of Dr Lal Pathlabs:

Dr Lal Pathlabs Share Long Term Investment Price Target:

Long Term Investment TagetsPriceQnt.Ratio

Dr Lal Pathlabs Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Dr Lal Pathlabs

S

  • Strengths Analysis will coming Soon.

W

  • Weakness Analysis will coming Soon.

O

  • Opportunity Analysis will coming Soon.

T

  • Threats Analysis will coming Soon.

Where we can See Dr Lal Pathlabs in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Dr Lal Pathlabs:

Dr Lal Pathlabs Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price

Dr Lal Pathlabs Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]

FAQ on Dr Lal Pathlabs:

Is it Good to Buy Dr Lal Pathlabs Share?

Yes, Dr Lal Pathlabs is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Dr Lal Pathlabs Debt Free Company?

Dr Lal Pathlabs is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Dr Lal Pathlabs Overvalued?

Currently Dr Lal Pathlabs is Trading at P/E Ratio which is

Is Dr Lal Pathlabs Better than Infosys?

Both and working as a

Why Dr Lal Pathlabs Share Price is Falling?

Do to Covid-19 pandemic Dr Lal Pathlabs Share drastically fall.

Why Dr Lal Pathlabs Share Price is Going Up?

Is Dr Lal Pathlabs Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Dr Lal Pathlabs at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Dr Lal Pathlabs’s Products/Projects:

Products/ProjectsDescription/Valuation
A.
B.
C.

IPO, Split, Bonus, Dividend Buyback History:

Dr Lal Pathlabs First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”79704″

Company Profile:

CEO NameOm Manchanda
CFO NameVed Prakash Goel
CEO SalaryN/A
Company Address 24, Tollygunge Circular Rd, Ajoy Nagar, Buroshibtalla, Behala, Kolkata, West Bengal 700053
Contact Number011 3988 5050 +91-124-3016500
Email Addresscs@lalpathlabs.com

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.